 |
 |
 |
| 1.
|
Tateishi U, Hasegawa T, Nojima T, Takegami T, Arai Y. MR features of extraskeletal myxoid chondrosarcoma. Skeletal Radiol 35: 27-33, 2006. |
| 2. |
Maeda T, Tateishi U, Sasajima Y, Hasegawa T, Daisaki H, Arai Y, Sugimura K. Atypical polypoid adenomyoma of the uterus: appearance on 18F-FDG PET/MRI fused images. Am J Roentgenol 186: 320-323, 2006. |
| 3. |
Yamaguchi U, Hasegawa T, Sakurai S, Sakuma Y, Takazawa Y, Hishima T, Mitsuhashi T, Sekine S, Chuman H, Shimoda T. Interobserver variability in histologic recognition, interpretation of KIT immunostaining and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract. Appl Immunohistochem Mol Morphol 14: 46-51, 2006. |
| 4. |
Matsui Y, Hasegawa T, Kubo T, Goto T, Yutaka K, Endo K, Bando Y, Yasui N. Intrapatellar tendon lipoma with chondro-osseous differentiation: detection of HMGA2-LPP fusion gene transcript. J Clin Pathol 59: 434-436, 2006. |
| 5. |
Endo M, Matsumura T, Yamaguchi T, Yamaguchi U, Morimoto Y, Nakatani F, Kawai A, Chuman H, Beppu Y, Shimoda T, Hasegawa T. Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas. Hum Pathol 37: 471-476, 2006. |
| 6. |
Hasegawa T. Role of immunohistochemical expression of KIT/CD117 in gastrointestinal stromal tumors. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 4: Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma, Edited by Hayat MA, Amsterdam, Elsevier, pp135-142, 2006. |
| 7. |
Miyake M, Tateishi U, Maeda T, Arai Y, Hasegawa T, Sugimura K. Diaphyseal medullary stenosis with pleomorphic malignant fibrous histiocytoma of the bone: 99mTc hydroxymethylenediphosphonate and 201Tl chloride scintigraphy findings. Ann Nucl Med 20: 233-236, 2006. |
| 8. |
Miyake M, Tateishi U, Maeda T, Arai Y, Hasegawa T, Sugimura K. Bronchial granular cell tumor: a case presenting secondary obstructive changes on CT. Radiat Med 24: 154-157, 2006. |
| 9. |
Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T. Glut-1 Expression and enhanced glucose metabolism are associated with tumor grade in bone and soft tissue sarcomas: a prospective evaluation by [F-18]-fluorodeoxyglucose positoron emission tomography. Eur J Nucl Med Mol Imaging 33: 683-691, 2006. |
| 10. |
Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Iwasaki H, Sonobe H, Goto H, Kusakabe H, Takahira T, Kobayashi C, Kawaguchi K, Saito T, Yamamoto H, Tamiya S, Iwamoto Y, Tsuneyoshi M. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod Pathol 19: 820-831, 2006. |
| 11. |
Tateishi U, Miyake M, Maeda T, Arai Y, Seki K, Hasegawa T. CT and MRI findings in KIT-weak or KIT-negative atypical gastrointestinal stromal tumors. Eur Radiol 16: 1537-1543, 2006. |
| 12. |
Miyake M, Tateishi U, Maeda T, Arai Y, Seki K, Hasegawa T, Sugimura K. Sclerosing perineurioma: tumor of the hand with a short T2. Skeletal Radiol 35: 543-546, 2006. |
| 13. |
Miyake M, Tateishi U, Maeda T, Arai Y, Seki K, Hasegawa T, Sugimura K. A case of ganglioneuroma presenting abnormal FDG uptake. Ann Nucl Med 20: 357-360, 2006. |
| 14. |
Tateishi U, Hasegawa T, Seki K, Terauchi T, Moriyama N, Arai Y. Disease activity and 18F-FDG uptake of organizing pneumonia: semi-quantitative evaluation using computed tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 33: 906-912, 2006. |
| 15. |
Matsui Y, Ueda T, Kubo T, Hasegawa T, Tomita Y, Okamoto M, Myoui A, Kakunaga S, Yasui N, Yoshikawa H. A novel type of EWS-CHOP fusion gene in myxoid liposarcoma. Biochem Biophys Res Commun 348: 437-440, 2006. |
| 16. |
Suehara Y, Kondo T, Fujii K, Hasegawa T, Kawai A, Seki K, Beppu Y, Nishimura T, Kurosawa H, Hirohashi S. Proteomics signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics 6: 4402-4409, 2006. |
| 17. |
Takahashi H, Nemoto T, Yoshida T, Honda H, Hasegawa T. Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method. BMC Bioinformatics 7: 399, 2006. |
| 18. |
Shimada S, Ishizawa T, Ishizawa K, Matsumura T, Hasegawa T, Hirose T. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum Pathol 37: 1123-1129, 2006. |
| 19. |
Osanai T, Tsuchiya T, Hasegawa T, Yamakawa M. Large benign rheumatoid nodules of the trunk in an elderly patient: radiologic appearance mimicking a soft-tissue sarcoma. Mod Rheumatol 16: 312-315, 2006. |
| 20. |
Maeda T, Tateishi U, Hasegawa T, Fujimoto H, Arai Y, Sugimura K. MRI of primary prostatic Wilms’ tumor in a young adult. Am J Roentogenol 187: W415-W417, 2006. |
| 21. |
Miyake M, Tateishi U, Maeda T, Arai Y, Seki K, Hasegawa T, Sugimura K. F-18 fluorodeoxyglucose positron emission tomography findings of Mazabraud syndrome. Clin Nucl Med 31: 627-629, 2006. |
| 22. |
Miyake M, Tateishi U, Maeda T, Arai Y, Seki K, Hasegawa T, Sugimura K. CT and MRI features of low-grade fibromyxoid sarcoma in the shoulder of a pediatric patient. Radiat Med 24: 511-514, 2006. |
| 23. |
Yonemori K, Hasegawa T, Shimizu C, Shibata T, Matsumoto K, Kouno T, Ando M, Katsumata N, Fujiwara Y. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast. Pathol Res Pract 202: 705-712, 2006. |
| 24. |
Okada K, Hasegawa T, Tateishi U, Endo M, Itoi E. Dedifferentiated chondrosarcoma having telangiectatic osteosarcoma-like features. J Clin Pathol 59: 1200-1202, 2006. |
| 25. |
Nakayama M, Mitsuhashi T, Shimizu Y, Ban S, Ogawa F, Ishihara O, Shimizu M. Immunohistochemical evaluation of KIT expression in sarcomas of the gynecologic region. Int J Gynecol Pathol 25: 70-76, 2006. |
| 26. |
Ishizawa K, Adachi D, Kuboi K, Yamaguchi T, Mitsuhashi T, Shimizu Y, Miura T, Nishimura S, Shimizu M, Hirose T. Multiple organ involvement in eosinophilic polymyositis: an autopsy report. Hum Pathol 37: 231-235, 2006. |
| 27. |
Mitsuhashi T, Itoh T, Shimizu Y, Ban S, Ogawa F, Hirose T, Shimizu M. Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle-cell variants. J Cutan Pathol 33: 246-252, 2006. |
| 28. |
Mitsuhashi T, Lauwers GY, Ban S, Mino-Kenudson M, Shimizu Y, Ogawa F, Ota S, Shimizu M. Post-gastric endoscopic mucosal resection surveillance biopsies: evaluation of mucosal changes and recognition of potential mimics of residual adenocarcinoma. Am J Surg Pathol 30: 650-656, 2006. |
| 29. |
Du X, Wang Q, Hirohashi Y, Greene MI. DIPA, which can localize to the centrosome, associates with p78/MCRS1/MSP58 and acts as a repressor of gene transcription. Exp Mol Pathol 81: 184-90, 2006. |
| 30. |
Kitamura H, Torigoe T, Honma I, Sato E, Asanuma H, Hirohashi Y, Sato N, Tsukamoto T. Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancer. Clin Cancer Res 12: 4641-4644, 2006. |
| 31. |
Hirohashi Y, Wang Q, Liu Q, Li B, Du X, Zhang H, Furuuchi K, Masuda K, Sato N, Greene MI. Centrosomal proteins Nde1 and Su48 form a complex regulated by phosphorylation. Oncogene 25: 6048-6055, 2006. |
| 32. |
Kitamura H, Torigoe T, Honma I, Asanuma H, Nakazawa E, Shimozawa K, Hirohashi Y, Sato E, Sato N, Tsukamoto T. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy. Urology 67: 955-959, 2006. |
| 33. |
Wang Q, Du X, Meinkoth J, Hirohashi Y, Zhang H, Liu Q, Richter M, Greene MI. Characterization of Su48, a centrosome protein essential for cell division. Proc Natl Acad Sci U S A 103: 6512-6517, 2006. |
| 34. |
Hirohashi Y, Wang Q, Liu Q, Du X, Zhang H, Sato N, Greene MI. p78/MCRS1 forms a complex with centrosomal protein Nde1 and is essential for cell viability. Oncogene 25: 4937-4946, 2006. |
| 35. |
Sato N, Hirohashi Y, Tsukahara T, Kamiguchi K, Ichimiya S, Sahara H, Takahashi N, Tsuruma T, Hirata K, Miyazaki A, Yamaguchi A, Hiratsuka H, Tsukamoto T, Kawaguchi S, Wada T, Yamashita T, Shijubo N, Takahashi H, Ogasawara M, Tamura Y, Torigoe T. Current progress and perspectives for human tumor immunotherapy. Tumor Res 41: 1-13, 2006. |
| 36. |
長谷川匡. 免疫組織化学染色と鑑別診断, 病理組織学的悪性度 (リスク分類). GIST研究会編. GISTの診断と治療. 実践マニュアル. 東京: エルゼビア・ジャパン pp78-92,2006. |
| 37. |
長谷川匡. ホルマリン固定パラフィン包埋組織から遺伝子変異/発現はどこまで検索できるか? 病理組織検体を用いたFISH検査の有効性と問題点. 病理と臨床 24: 69-76, 2006. |
| 38. |
長谷川匡. GISTの病理診断. 消化器外科 29: 149-158, 2006. |
| 39. |
長谷川匡. 間葉系腫瘍と分子標的治療（特集 分子標的治療と病理）. 病理と臨床 24: 611-617, 2006. |
| 40. |
長谷川匡. ホルマリン固定パラフィン包埋標本?軟部腫瘍でのFISH?その有効性と問題点（今月の主題 ホルマリン固定パラフィン包埋標本からどこまで遺伝子検索は可能か？）. 臨床検査 50: 745-752, 2006. |
| 41. |
長谷川匡. 軟部肉腫における臨床病理学的予後因子とMIB-1標識率（特集 軟部肉腫の分子病理と診断）. 細胞 38: 398-401, 2006. |
| 42. |
村上英樹、富田勝郎、川原範夫、土屋弘行、山口岳彦. 脊椎骨肉腫の”en bloc”切除標本から得た新知見：病理から手術へのフィードバック. 臨床整形外科 41: 183-189, 2006. |
| 43. |
山口岳彦. 骨転移の病理組織学的発現機序. MSD (Medical Science Digest) 32: 138-141, 2006. |
| 44. |
三橋智子. Phosphaturic mesenchymal tumorの診断と最近の知見．病理と臨床 24: 546-547, 2006. |
| 45. |
五十嵐健史、廣橋良彦、鳥越俊彦. 腫瘍組織における HLA class I down-regulation と免疫逃避機構. Annual Review 免疫 2006、中外医学社 39-46, 2006. |
|
|
 |
